Radius Health officially withdraws $62 million US IPO

By Renaissance Capital,

Shutterstock photo

Radius Health, a biotech developing treatments to restore bone loss from osteoporosis, withdrew its plans for an initial public offering in a filing with the SEC on Thursday citing poor market conditions. The Cambridge, MA-based company, which was founded in 2003, initially postponed its offering on Tuesday, November 14. UBS Investment Bank and Leerink Swann were set to be the joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines IPOs
Referenced Stocks: RDUS

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com